On the relationship between the structure and antimycobacterial activity of substituted N-benzylsalicylamides

被引:21
作者
Waisser, K
Perina, M
Klimesová, V
Kaustová, J
机构
[1] Fac Pharm, Dept Inorgan & Organ Chem, CZ-50005 Hradec Kralove, Czech Republic
[2] Inst Hyg, Natl Reference Lab Mycobacterium Kansasii, CZ-72892 Ostrava, Czech Republic
关键词
tuberculostatic; antituberculotics; salicylamides; QSAR; substituent effects; structure; activity relationships; antimicrobial activity; Free-Wilson method;
D O I
10.1135/cccc20031275
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Sixty-six N-benzylsalicylamides substituted in the acyl moiety in positions 3, 4 or 5 and in position 4 on the benzylic aromatic ring were synthesized. The compounds were tested for in vitro antimycobacterial activity against Mycobacterium tuberculosis, Mycobacterium kansasii and Mycobacterium avium. To evaluate structure-antimycobacterial activity relationships (QSARs), approaches based on the Free-Wilson as well as a combination of the Free-Wilson and Hansch methods were employed (substituent constants were used to describe the influence of the benzyl substituents, indicator parameters were used for the substituents on the acyl moiety). The use of the Hammett constants for benzyl substituents was not important for QSAR equations. The quadratic representation of lipophilicity parameters (pi(2)) was significant only in QSAR equations of antimycobacterial activity against M. avium.
引用
收藏
页码:1275 / 1294
页数:20
相关论文
共 14 条
  • [1] Chen H, 1996, ANTI-CANCER DRUG DES, V11, P49
  • [2] CLEMENSE H, 1970, CHIM THER, V5, P188
  • [3] Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: Pharmacophore identification based on the screening hit closantel
    Hlasta, DJ
    Demers, JP
    Foleno, BD
    Fraga-Spano, SA
    Guan, JH
    Hilliard, JJ
    Macielag, MJ
    Ohemeng, KA
    Sheppard, CM
    Sui, ZH
    Webb, GC
    Weidner-Wells, MA
    Werblood, H
    Barrett, JF
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (14) : 1923 - 1928
  • [4] KORGER G, 1960, ARZNEIMITTEL-FORSCH, V10, P104
  • [5] KUCHAR M, 1987, VYUZITI KVANTITATIVN, P51
  • [6] SYNTHESIS AND GERMICIDAL ACTIVITY OF HALOGENATED SALICYLANILIDES AND RELATED COMPOUNDS
    LEMAIRE, H
    SCHRAMM, CH
    CAHN, A
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1961, 50 (10) : 831 - &
  • [7] Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria
    Macielag, MJ
    Demers, JP
    Fraga-Spano, SA
    Hlasta, DJ
    Johnson, SG
    Kanojia, RM
    Russel, RK
    Sui, ZH
    Weidner-Wells, MA
    Werblood, H
    Foleno, BD
    Goldschmidt, RM
    Loeloff, MJ
    Webb, GC
    Barrett, JF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (16) : 2939 - 2945
  • [8] N-ARALKYLSALICYLAMIDES
    PARIS, GY
    CHAMBERS, CH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1966, 9 (06) : 971 - &
  • [9] Waisser K, 2003, PHARMAZIE, V58, P83
  • [10] Waisser K, 2001, RATIONAL APPROACHES TO DRUG DESIGN, P214